P. Lynette Page, D. D. S

NPI: 1477700532
Total Payments
$4,015
2024 Payments
$163.35
Companies
9
Transactions
29

Payment Breakdown by Category

Research$3,338 (83.1%)
Food & Beverage$419.43 (10.4%)
Gifts$182.41 (4.5%)
Consulting$75.00 (1.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $3,338 7 83.1%
Food and Beverage $419.43 18 10.4%
Gift $182.41 3 4.5%
Consulting Fee $75.00 1 1.9%

Payments by Type

Research
$3,338
7 transactions
General
$676.84
22 transactions

Top Paying Companies

Company Total Records Latest Year
Regeneron Pharmaceuticals, Inc. $2,988 6 $0 (2022)
Midmark Corporation $350.00 1 $0 (2017)
Align Technology, Inc. $293.14 9 $0 (2024)
Straumann USA LLC $182.41 3 $0 (2021)
Salvin Dental Specialties, Inc. $61.75 1 $0 (2021)
Philips Electronics North America Corporation $55.16 4 $0 (2023)
VOCO America Inc. $50.92 3 $0 (2021)
Janssen Biotech, Inc. $17.52 1 $0 (2019)
Zimmer Biomet Holdings, Inc. $15.94 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $163.35 3 Align Technology, Inc. ($163.35)
2023 $12.75 1 Philips Electronics North America Corporation ($12.75)
2022 $1,794 9 Regeneron Pharmaceuticals, Inc. ($1,667)
2021 $1,561 9 Regeneron Pharmaceuticals, Inc. ($1,321)
2019 $17.52 1 Janssen Biotech, Inc. ($17.52)
2018 $15.30 2 Align Technology, Inc. ($15.30)
2017 $450.94 4 Midmark Corporation ($350.00)

All Payment Transactions

29 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/19/2024 Align Technology, Inc. Invisalign (Device) Food and Beverage Cash or cash equivalent $26.44 General
Category: Orthodontics
05/22/2024 Align Technology, Inc. Invisalign (Device) Consulting Fee Cash or cash equivalent $75.00 General
Category: Orthodontics
02/12/2024 Align Technology, Inc. Invisalign (Device) Food and Beverage Cash or cash equivalent $61.91 General
Category: Orthodontics
04/26/2023 Philips Electronics North America Corporation (3099) PTB Und (Device) Food and Beverage Cash or cash equivalent $12.75 General
Category: Medical Device
11/16/2022 Philips Electronics North America Corporation (8027) Other (Device) Food and Beverage Cash or cash equivalent $13.00 General
Category: Medical Device
08/09/2022 Philips Electronics North America Corporation (8027) Other (Device) Food and Beverage Cash or cash equivalent $14.21 General
Category: Medical Device
06/16/2022 Align Technology, Inc. Invisalign (Device) Food and Beverage Cash or cash equivalent $57.14 General
Category: Orthodontics
06/01/2022 Regeneron Pharmaceuticals, Inc. DUPIXENT (Biological) In-kind items and services $845.67 Research
Study: A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) • Category: INFLAMMATION AND IMMUNOLOGY
03/14/2022 Philips Electronics North America Corporation (8027) Other (Device) Food and Beverage Cash or cash equivalent $15.20 General
Category: Medical Device
03/09/2022 Align Technology, Inc. Invisalign (Device) Food and Beverage Cash or cash equivalent $14.33 General
Category: Orthodontics
02/25/2022 Regeneron Pharmaceuticals, Inc. DUPIXENT (Biological) In-kind items and services $508.80 Research
Study: A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) • Category: INFLAMMATION AND IMMUNOLOGY
02/23/2022 Regeneron Pharmaceuticals, Inc. DUPIXENT (Biological) In-kind items and services $312.60 Research
Study: A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) • Category: INFLAMMATION AND IMMUNOLOGY
02/15/2022 Align Technology, Inc. Invisalign (Device) Food and Beverage Cash or cash equivalent $13.34 General
Category: Orthodontics
12/15/2021 Straumann USA LLC Gift Cash or cash equivalent $97.41 General
12/12/2021 Regeneron Pharmaceuticals, Inc. DUPIXENT (Biological) In-kind items and services $845.67 Research
Study: A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) • Category: INFLAMMATION AND IMMUNOLOGY
10/13/2021 Regeneron Pharmaceuticals, Inc. DUPIXENT (Biological) In-kind items and services $188.55 Research
Study: A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) • Category: INFLAMMATION AND IMMUNOLOGY
09/14/2021 Salvin Dental Specialties, Inc. Food and Beverage In-kind items and services $61.75 General
08/31/2021 Regeneron Pharmaceuticals, Inc. DUPIXENT (Biological) In-kind items and services $286.55 Research
Study: A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) • Category: INFLAMMATION AND IMMUNOLOGY
06/24/2021 VOCO America Inc. Structur Premium (Device), Structur 3, Admira Fusion Food and Beverage In-kind items and services $14.24 General
Category: Restorative Dentistry
04/22/2021 Align Technology, Inc. Invisalign (Device) Food and Beverage Cash or cash equivalent $29.68 General
Category: Orthodontics
04/15/2021 VOCO America Inc. Admira Fusion x-tra (Device), Bifix Temp, Structur Premium Food and Beverage In-kind items and services $16.65 General
Category: Restorative Dentistry
03/04/2021 VOCO America Inc. Admira Fusion x-tra (Device), IonoStar Plus, Meron Plus QM Food and Beverage In-kind items and services $20.03 General
Category: Restorative Dentistry
10/14/2019 Janssen Biotech, Inc. SIMPONI (Biological) Food and Beverage In-kind items and services $17.52 General
Category: Immunology
08/28/2018 Align Technology, Inc. Invisalign (Device) Food and Beverage In-kind items and services $5.38 General
Category: Orthodontics
03/12/2018 Align Technology, Inc. Invisalign (Device) Food and Beverage In-kind items and services $9.92 General
Category: Orthodontics

Research Studies & Clinical Trials

Study Name Company Amount Records
A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) Regeneron Pharmaceuticals, Inc. $2,988 6

About P. Lynette Page, D. D. S

P. Lynette Page, D. D. S is a General Practice healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1477700532.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, P. Lynette Page, D. D. S has received a total of $4,015 in payments from pharmaceutical and medical device companies, with $163.35 received in 2024. These payments were reported across 29 transactions from 9 companies. The most common payment nature is "" ($3,338).

Practice Information

  • Specialty General Practice
  • Location Dallas, TX
  • Active Since 08/20/2008
  • Last Updated 01/09/2026
  • Taxonomy Code 1223G0001X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1477700532

Products in Payments

  • DUPIXENT (Biological) $2,988
  • Invisalign (Device) $293.14
  • (8027) Other (Device) $42.41
  • Admira Fusion x-tra (Device) $36.68
  • SIMPONI (Biological) $17.52
  • All Osseotite Implants (Device) $15.94
  • Structur Premium (Device) $14.24
  • (3099) PTB Und (Device) $12.75

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

General Practice Doctors in Dallas